Symptomatic Benefit from EradicatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia
- 24 December 1998
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (26), 1869-1874
- https://doi.org/10.1056/nejm199812243392601
Abstract
The eradication of Helicobacter pylori infection is beneficial in patients with gastric or duodenal ulcers. The value of eradicating the infection in patients with dyspepsia and no evidence of ulcer disease is not known.Keywords
This publication has 25 references indexed in Scilit:
- Assessment of symptomatic response as predictor ofHelicobacter pylori status following eradication therapy in patients with ulcerGut, 1998
- The Glasgow Dyspepsia Severity Score ??? a tool for the global measurement of dyspepsiaEuropean Journal of Gastroenterology & Hepatology, 1996
- Helicobacter pyloriand Non-ulcer DyspepsiaScandinavian Journal of Gastroenterology, 1996
- Helicobacter pyloriInfection and DyspepsiaScandinavian Journal of Gastroenterology, 1996
- Review article: functional dyspepsia—should treatment be targeted on disturbed physiology?Alimentary Pharmacology & Therapeutics, 1995
- Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) ofHelicobacter pyloriEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?BMJ, 1993
- Pathophysiology and Treatment of Functional DyspepsiaScandinavian Journal of Gastroenterology, 1993
- Economic Costs of Functional DyspepsiaPharmacoEconomics, 1992
- PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORIThe Lancet, 1988